Clinical trials data
Symbol Coding in stroke trials: 61 registered studies
Every registered stroke study on ClinicalTrials.gov that names Symbol Coding in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered stroke studies name it in an outcome measure
- 61
- Name it in a primary outcome, 21%
- 13 of 61
Tests named in the same studies
- 1
Trail Making Test21 studies, 5 as a primary outcome
- 2
Verbal Fluency18 studies, 6 as a primary outcome
- 3
Digit Span Test16 studies, 4 as a primary outcome
- 4
Stroop Color-Word Test13 studies, 4 as a primary outcome
- 5
Verbal Learning11 studies, 5 as a primary outcome
- 6
Category Fluency5 studies, 1 as a primary outcome
- 7
Picture Naming Test5 studies, 1 as a primary outcome
- 8
Complex Figure Copy and Recall4 studies, 1 as a primary outcome
- 9
Tower Planning4 studies, 0 as a primary outcome
- 10
Matrix Reasoning3 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 7 | 0 |
| 2018 | 7 | 2 |
| 2019 | 4 | 1 |
| 2020 | 5 | 0 |
| 2021 | 3 | 0 |
| 2022 | 6 | 2 |
| 2023 | 10 | 2 |
| 2024 | 5 | 2 |
| 2025 | 10 | 3 |
| 2026 | 2 | 0 |
Phases and study sizes
By phase
- Phase 211 studies, 3 as a primary outcome
- Phase 32 studies, 0 as a primary outcome
- Phase 41 studies, 1 as a primary outcome
- Not applicable41 studies, 7 as a primary outcome
- Observational6 studies, 2 as a primary outcome
Participants per study
- Phase 270 median, 34 to 100
- Not applicable76 median, 41 to 104
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 11 | 70 | 34 to 100 |
| Not applicable | 41 | 76 | 41 to 104 |
When stroke trials measure it
Latest time point of each outcome
- Within a day10 outcomes, 1 as a primary outcome
- Up to 4 weeks8 outcomes, 1 as a primary outcome
- 1 to 3 months22 outcomes, 4 as a primary outcome
- 3 to 6 months11 outcomes, 4 as a primary outcome
- 6 to 12 months8 outcomes, 2 as a primary outcome
- Over 2 years1 outcomes, 0 as a primary outcome
- No duration given1 outcomes, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
60 of the 61 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting16 studies, 4 as a primary outcome
- Not yet recruiting4 studies, 0 as a primary outcome
- Active, not recruiting6 studies, 1 as a primary outcome
- Completed18 studies, 4 as a primary outcome
- Stopped early3 studies, 0 as a primary outcome
- Status unknown14 studies, 4 as a primary outcome
What they test
- Behavioral11 studies, 3 as a primary outcome
- Drug11 studies, 3 as a primary outcome
- Device18 studies, 5 as a primary outcome
- Dietary supplement1 studies, 0 as a primary outcome
- Procedure4 studies, 0 as a primary outcome
- Diagnostic test5 studies, 1 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other19 studies, 3 as a primary outcome
- None given2 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States14 studies, 4 as a primary outcome
- Italy11 studies, 4 as a primary outcome
- Canada7 studies, 1 as a primary outcome
- China6 studies, 1 as a primary outcome
- Belgium5 studies, 0 as a primary outcome
- Denmark5 studies, 0 as a primary outcome
- Germany3 studies, 1 as a primary outcome
- Netherlands3 studies, 0 as a primary outcome
- Sweden3 studies, 0 as a primary outcome
- Australia2 studies, 1 as a primary outcome
- Brazil2 studies, 0 as a primary outcome
- France2 studies, 0 as a primary outcome
34 countries in all. A study with sites in several counts in each; 4 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed stroke studies that name Symbol Coding: 8 of 18, 44%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed stroke studies that name Symbol Coding | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 6% | 776, 10% |
| Results on ClinicalTrials.gov only | 3, 17% | 1,139, 14% |
| A results paper only | 4, 22% | 1,711, 22% |
| Neither | 10, 56% | 4,327, 54% |
The 61 studies
61 studies match. 13 name Symbol Coding in a primary outcome. Median size 78 participants. Median time to the primary outcome: 15 weeks.
Loading 61 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 7 | 0 |
| 2018 | 7 | 2 |
| 2019 | 4 | 1 |
| 2020 | 5 | 0 |
| 2021 | 3 | 0 |
| 2022 | 6 | 2 |
| 2023 | 10 | 2 |
| 2024 | 5 | 2 |
| 2025 | 10 | 3 |
| 2026 | 2 | 0 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 5, other 56. Interventional 55, observational 6.
As a primary outcomeSecondary or other outcomeSymbol Coding
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07807176 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07445841 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07343895 | Start2025 | PhaseNot applicable | ConditionsStroke, Cardiovascular disease | Participants4,000 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07220538 | Start2025 | PhasePhase 4 | ConditionsStroke | Participants400 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07199322 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07159256 | Start2025 | PhaseObservational | ConditionsStroke | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07116187 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07030985 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants55 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06978413 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants160 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06968923 | Start2018 | PhaseNot applicable | ConditionsStroke | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06956183 | Start2025 | PhaseNot applicable | ConditionsStroke, Pain and fatigue | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06852209 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06834490 | Start2019 | PhasePhase 3 | ConditionsStroke | Participants318 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06822140 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants144 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06547827 | Start2024 | PhaseNot applicable | ConditionsStroke | Participants596 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06402123 | Start2024 | PhasePhase 2 | ConditionsStroke | Participants43 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06384495 | Start2024 | PhaseNot applicable | ConditionsStroke | Participants3 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06330298 | Start2021 | PhaseNot applicable | ConditionsStroke, Multiple sclerosis, Cancer | Participants84 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06109324 | Start2023 | PhaseNot applicable | ConditionsStroke | Participants126 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06096350 | Start2024 | PhaseObservational | ConditionsStroke | Participants55 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06027788 | Start2023 | PhaseNot applicable | ConditionsStroke, Delirium, surgery and intensive care, Cardiovascular disease | Participants842 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06021470 | Start2023 | PhaseNot applicable | ConditionsStroke | Participants64 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06009770 | Start2023 | PhaseNot applicable | ConditionsStroke, Parkinson's disease, Multiple sclerosis | Participants90 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05992571 | Start2023 | PhaseNot applicable | ConditionsStroke | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05976152 | Start2024 | PhasePhase 3 | ConditionsStroke | Participants3,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many stroke trials use Symbol Coding?
61 registered stroke studies on ClinicalTrials.gov name it in an outcome measure, 13 of them in a primary outcome: 5% of the condition's 1,233 studies with a cognitive outcome, against 9% of all of them. It is the 8th most named test in stroke trials.
Which tests do stroke trials use with Symbol Coding?
The Trail Making Test (21 studies), Verbal Fluency (18 studies) and the Digit Span Test (16 studies).
How many participants do phase 2 stroke trials that use Symbol Coding enroll?
Half of the phase 2 studies that name it enroll 70 participants or fewer, and the middle half enroll 34 to 100. 11 of them give a size.
When do stroke trials measure Symbol Coding?
Half of the primary outcomes that name Symbol Coding are measured within 15 weeks of the start, and the middle half from 6 weeks to 6 months. 12 primary outcomes give a duration.
How many completed stroke trials that use Symbol Coding have reported results?
8 of the 18 completed studies that name it, 44%, have reported results: 4 posted them on ClinicalTrials.gov, 5 have a results paper linked to the registry record, and 1 did both. The other 10 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Symbol Key Game and Symbol Coding as one test family, so this page counts their studies together.
Run Symbol Coding in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.